Fig. 5From: Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancerDFS analysis in the postmenopausal subgroup. a PFS: 10y endocrine therapy versus 5y endocrine therapy in postmenopausal subgroup, b PFS: >8y endocrine therapy versus < 8y endocrine therapy in postmenopausal subgroupBack to article page